Answers are grounded in this paper and cite their sources.
This research demonstrates the inhibition of Mycobacterium tuberculosis enzyme activity by a sulfur-modified cyclic dinucleotide analog, indicating potential therapeutic insights.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hanuman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: